Search research articles
Contact Us
Filters
Showing results (61-70 of 302) with videos related to
Page
of 31
Sort By:
Journal of Interferon Research
|
September 1, 1989
Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors
K Oberg, G V Alm
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon
E T Janson, K Oberg
Current Pharmaceutical Design
|
September 25, 1999
Somatostatin receptor ligands and their use in the treatment of endocrine disorders
E T Janson, K Oberg
British Journal of Cancer
|
November 1, 1995
Expression and prognostic significance of Bcl-2 in ovarian tumours
R Henriksen, E Wilander, K Oberg
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system
A Chaudhry, K Funa, K Oberg
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1992
A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system
A Chaudhry, K Oberg, E Wilander
Digestion
|
August 15, 2000
Tumor markers in neuroendocrine tumors
B Eriksson, K Oberg, M Stridsberg
Acta Chirurgica Scandinavica. Supplementum
|
January 1, 1988
Neuroendocrine tumours of the upper gastrointestinal tract and pancreas
K Oberg, B Eriksson, M Lundqvist
Acta Medica Scandinavica
|
January 1, 1981
HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour
K Oberg, L Wide, H Boström
Journal of Rehabilitation Research and Development
|
January 1, 1993
Basic gait parameters: reference data for normal subjects, 10-79 years of age
T Oberg, A Karsznia, K Oberg
Page
of 31
Search research articles
Search
Showing results (61-70 of 302) with videos related to
Sort By:
Page
of 31
Journal of Interferon Research
|
September 1, 1989
Development of neutralizing interferon antibodies after treatment with recombinant interferon-alpha 2b in patients with malignant carcinoid tumors
K Oberg, G V Alm
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon
E T Janson, K Oberg
Current Pharmaceutical Design
|
September 25, 1999
Somatostatin receptor ligands and their use in the treatment of endocrine disorders
E T Janson, K Oberg
British Journal of Cancer
|
November 1, 1995
Expression and prognostic significance of Bcl-2 in ovarian tumours
R Henriksen, E Wilander, K Oberg
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1993
Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system
A Chaudhry, K Funa, K Oberg
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 1, 1992
A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system
A Chaudhry, K Oberg, E Wilander
Digestion
|
August 15, 2000
Tumor markers in neuroendocrine tumors
B Eriksson, K Oberg, M Stridsberg
Acta Chirurgica Scandinavica. Supplementum
|
January 1, 1988
Neuroendocrine tumours of the upper gastrointestinal tract and pancreas
K Oberg, B Eriksson, M Lundqvist
Acta Medica Scandinavica
|
January 1, 1981
HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour
K Oberg, L Wide, H Boström
Journal of Rehabilitation Research and Development
|
January 1, 1993
Basic gait parameters: reference data for normal subjects, 10-79 years of age
T Oberg, A Karsznia, K Oberg
Page
of 31